Your browser doesn't support javascript.
loading
Structure, receptor recognition and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein
M. Alejandra Tortorici; Alexandra C Walls; Anshu Joshi; Young-Jun Park; Rachel T Eguia; Terry Stevens-Ayers; Michael J Boeckh; Amalio Talenti; Antonio Lanzavecchia; Davide Corti; Jesse D Bloom; David Veesler.
Afiliação
  • M. Alejandra Tortorici; University of Washington
  • Alexandra C Walls; University of Washington
  • Anshu Joshi; University of Washington
  • Young-Jun Park; University of Washington
  • Rachel T Eguia; Fred Hutchinson Cancer Research Center
  • Terry Stevens-Ayers; Fred Hutchinson Cancer Research Center
  • Michael J Boeckh; Fred Hutchinson Cancer Research Center
  • Amalio Talenti; Vir Biotechnology
  • Antonio Lanzavecchia; Vir Biotechnology
  • Davide Corti; Humabs Biomed SA
  • Jesse D Bloom; Fred Hutchinson Cancer Research Center
  • David Veesler; University of Washington
Preprint em En | PREPRINT-BIORXIV | ID: ppbiorxiv-465646
ABSTRACT
The recent isolation of CCoV-HuPn-2018 from a child respiratory swab indicates that more coronaviruses are spilling over to humans than previously appreciated. Here, we determined cryo-electron microscopy structures of the CCoV-HuPn-2018 spike glycoprotein trimer in two distinct conformational states and identified that it binds canine, feline and porcine aminopeptidase N (APN encoded by ANPEP) orthologs which serve as entry receptors. Introduction of an oligosaccharide at position N739 of human APN renders cells susceptible to CCoV-HuPn-2018 spike-mediated entry, suggesting that single nucleotide polymorphisms could account for the detection of this virus in some individuals. Human polyclonal plasma antibodies elicited by HCoV-229E infection and a porcine coronavirus monoclonal antibody inhibit CCoV-HuPn-2018 S-mediated entry, indicating elicitation of cross-neutralizing activity among -coronaviruses. These data provide a blueprint of the CCoV-HuPn-2018 infection machinery, unveil the viral entry receptor and pave the way for vaccine and therapeutic development targeting this zoonotic pathogen.
Licença
cc_by_nc_nd
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-BIORXIV Tipo de estudo: Rct Idioma: En Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-BIORXIV Tipo de estudo: Rct Idioma: En Ano de publicação: 2021 Tipo de documento: Preprint